Skip to main content
OpenTrials
Completed

NCT Number: NCT02719353

A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses

The aim of this study is to validate the clinical of comfilcon A extended range high add center near (CN) multifocal lenses in existing contact lens wearers against the current comfilcon A high add multifocal lenses.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CORL, Indiana University

Bloomington, Indiana, 47405, United States

About this study

This study is a 13-subject, randomized, prospective, single site, daily wear, single-masked (to the subject), bilateral, 4-day cross-over, dispensing study comparing the comfilcon A extended range multifocal test lens against the comfilcon A multifocal control lens.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

A person is eligible for inclusion in the study if he/she:

  • Has had a self-reported oculo-visual examination in the last two years
  • Is 50 years of age or greater and has full legal capacity to volunteer
  • Is able to read and understand the informed consent
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Has a spherical distance contact lens prescription between -1.00 and -5.00D (Diopters) (inclusive)
  • Near Add Power requirement of +2.25D or greater
  • Has spectacle cylinder 0.75 D in both eyes
  • Has normal binocularity (no amblyopia, no strabismus, no habitually uncorrected anisometropia ≥ 2.00D)
  • Has monocular best-corrected distance visual acuity of 20/30 or better in each eye
  • Has clear corneas and no active ocular disease
  • Has not worn gas permeable contact lenses for 1 month prior to the study

Exclusion criteria

A person will be excluded from the study if he/she:

  • Has never worn contact lenses before
  • Has any systemic disease affecting ocular health
  • Is using any systemic or topical medications that will affect ocular health
  • Has any ocular pathology or abnormality that would affect the wearing of contact lenses
  • Is aphakic (i.e. missing their natural lens inside their eye)
  • Has uncorrected anisometropia (i.e. difference in the prescription between the eyes) of ≥2.00 D
  • Has undergone corneal refractive surgery
  • Is participating in any other type of eye related clinical or research study.

Treatment and study plan

comfilcon A Extended Range test lens

Device

contact lens

comfilcon A control lens

Device

contact lens

Primary outcomes

  1. Visual Acuity

    Time frame: 4 days

    Visual acuity was measured at distance, intermediate and near conditions for test and control lens was assessed by LogMAR.

  2. Visual Performance

    Time frame: 4 days

    Subjective assessment of visual performance for test and control lens is assessed on a scale 0-100, 0=extremely poor vision all of the time and cannot function, 100= excellent vision all of the time).

Secondary outcomes

  1. Subjective Ratings for Comfort

    Time frame: Baseline

    Subjective ratings for comfort was assessed for test and control lens on a Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever).

  2. Subjective Ratings for Comfort

    Time frame: 4 days

    Subjective ratings for comfort was assessed for test and control lens on a Scale 0-100, 0=cannot be worn, causes pain, 100=cannot be felt ever).

  3. Subjective Ratings for Dryness

    Time frame: Baseline

    Subjective ratings for dryness was assessed for test and control lens on a scale 0-100, 0=cannot be worn, extremely dry, 100=no dryness experienced at any time).

  4. Subjective Ratings for Dryness

    Time frame: 4 days

    Subjective ratings for dryness was assessed for test and control lens on a scale 0-100, 0=cannot be worn, extremely dry, 100=no dryness experienced at any time).

  5. Lens Handling

    Time frame: 4 Days

    Subjective ratings for handling (ease of insertion and removal) was assessed for test and control lens on a scale 0-100, 0=very difficult to handle, 100=easy to handle).

  6. Average Daily Wearing Time

    Time frame: 4 days

    Average daily wearing time for test and control lens is assessed in hours.

  7. Lens Fit

    Time frame: 4 days

    Lens fit acceptance (general fit characteristics) is assessed for test and control lens on a 0-4 grading system in 0.25 steps where 0 represented very poor fit.

  8. Bulbar Hyperemia

    Time frame: 4 days

    Bulbar hyperemia was assessed on a scale of 0-4 and was used in 0.50 steps, with 0 indicating no hyperemia and 4 indicating severe hyperemia.

  9. Limbal Hyperemia

    Time frame: 4 days

    Limbal hyperemia was assessed on a scale of 0-4 and was used in 0.50 steps, with 0 indicating no hyperemia and 4 indicating severe hyperemia.

  10. Subjective Satisfaction

    Time frame: 4 days

    Subjective satisfaction for test and control lens was assessed on a scale 0-100, 0=extremely dissatisfied, 100=very satisfied)

  11. Subjective Preference for Near Vision

    Time frame: 4 days

    Subjective preference for near vision for test and control contact lenses. comfort, vision, handling, satisfaction.

  12. Subjective Preference for Distance Vision

    Time frame: 4 days

    Subjective preference for distance vision for test and control contact lenses.

  13. Subjective Preference for Intermediate Vision

    Time frame: 4 days

    Subjective preference for intermediate vision for test and control contact lenses.

  14. Subjective Preference for Overall Vision

    Time frame: 4 days

    Subjective preference for overall vision for test and control contact lenses.

  15. Subjective Preference for Comfort

    Time frame: 4 days

    Subjective preference for comfort for test and control contact lenses.

  16. Subjective Overall Lens Preference

    Time frame: 4 days

    Subjective overall lens preference for test and control contact lenses.

Sponsors and collaborators

Lead sponsor

CooperVision, Inc.

Industry

Registry information

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Mar 25, 2016
Registry last updated
Jul 30, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.